NGF and Alzheimer disease: In this framework, any data strengthening the causal molecular link between NGF dyshomeostasis and early-stage AD features could be helpful in assisting the development of more effective neuroprotective and disease-modifying non-invasive cholinergic therapy for the amelioration of AD symptomology.